Sandoval Elisabeth 4
4 · Intersect ENT, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Disposition from Tender
Stock Options (Right to buy)
2022-05-13$28.25/sh−15,896$449,062→ 0 totalExercise: $20.98Exp: 2031-04-04→ Common Stock (15,896 underlying)
Footnotes (1)
- [F1]Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes.